Segall Bryant & Hamill LLC Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Segall Bryant & Hamill LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 83,570 shares of the healthcare conglomerate's stock after selling 5,605 shares during the period. UnitedHealth Group comprises about 0.7% of Segall Bryant & Hamill LLC's portfolio, making the stock its 23rd largest holding. Segall Bryant & Hamill LLC's holdings in UnitedHealth Group were worth $43,770,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new position in UnitedHealth Group during the fourth quarter worth approximately $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. IAG Wealth Partners LLC acquired a new position in UnitedHealth Group in the 1st quarter valued at about $42,000. Finally, Kapitalo Investimentos Ltda acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $41,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on UNH shares. Deutsche Bank Aktiengesellschaft reduced their target price on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Piper Sandler decreased their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Mizuho reduced their target price on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $414.35.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO John F. Rex purchased 17,175 shares of the stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $4.15 during mid-day trading on Thursday, reaching $288.34. 12,760,444 shares of the stock were exchanged, compared to its average volume of 7,775,680. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a 50 day simple moving average of $308.39 and a 200-day simple moving average of $436.45. The stock has a market capitalization of $261.57 billion, a P/E ratio of 12.04, a P/E/G ratio of 1.40 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same quarter last year, the business posted $6.91 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 3.07%. UnitedHealth Group's dividend payout ratio is 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.